2011 Clinical Trials Session

Friday, April 15, 2011
12:00 p.m. – 1:30 p.m.

This midday seminar covers important clinical topics identified from other society meetings that affect patient care. The latest updates within several clinical trials conducted over the course of the last year will be presented with an open panel discussion at the conclusion. This session will cover the following scientific topics.

12:00 p.m. – 12:15 p.m.

Francois Chollet, MD
"FLAME: A Multicenter Randomized Double-Blind Placebo-Controlled Trial with Fluoxetine in Motor Recovery of Patients with Acute Ischemic Stroke"

12:15 p.m. – 12:30 p.m.

Jeremy Shefner, MD, PhD
"A Phase 2, Single Dose Study of CK-2017357, a Skeletal Muscle Troponin Activator in Patients with ALS"

12:30 p.m. – 12:45 p.m.

Karl Kieburtz, MD, FAAN
"Effect of Pridopidine on Motor Function in Patients with Huntington Disease: Results from the HART Study"

12:45 p.m. – 1:00 p.m.

Vera Bril, MD
"Comparison of IVIG and PLEX in Patients with Myasthenia Gravis"

1:00 p.m. – 1:15 p.m.

Giancarlo Comi, MD
"Oral Laquinimod Reduced Relapse Rate and Delayed Progression of Disability in Allegro, a Placebo-Controlled Phase III Trial for Relapsing-Remitting Multiple Sclerosis"

1:15 p.m. – 1:30 p.m.

Open panel with speakers and closing remarks